Home › Research › Biomarkers
Amyloid PET/MRI in the differential diagnosis of dementia
Vercher-Conejero JL, Rubbert C, Kohan AA, Partovi S, O'Donnell JK.. Clinical nuclear medicine, 2014-06-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The potential of brain imaging has grown rapidly with new modalities, hybrid combinations of existing modalities, and novel metabolic tracers. F-florbetapir is an amyloid plaque-binding molecule labeled to F that allows positron imaging of the amyloid deposition in the brain. This protein deposition is known to be one of the features in Alzheimer disease and therefore can be of interest in the differential diagnosis of dementia. We present 2 cases combining the new hybrid imaging modality PET/MRI, which offers molecular and morphological information, with F-florbetapir in the differential diagnosis of dementia.
What this study adds
Evidence grade: Low
This report describes two patients in whom PET/MRI combined with F-florbetapir was used to help tell different dementias apart. It is a small two-case report, so it does not show whether this imaging approach changes treatment, cure, or prevention of Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Vercher-Conejero, J. L., Rubbert, C., Kohan, A. A., Partovi, S., & O'Donnell, J. K. (2014). Amyloid PET/MRI in the differential diagnosis of dementia. Clinical nuclear medicine. https://doi.org/10.1097/rlu.0b013e31829b9e5f
Vancouver
Vercher-Conejero JL, Rubbert C, Kohan AA, Partovi S, O'Donnell JK. Amyloid PET/MRI in the differential diagnosis of dementia. Clinical nuclear medicine. 2014. doi:10.1097/rlu.0b013e31829b9e5f. PMID: 23856830.
BibTeX
@article{vercherconejero2014-23856830,
author = {Vercher-Conejero, J. L. and Rubbert, C. and Kohan, A. A. and Partovi, S. and O'Donnell, J. K.},
title = {{Amyloid PET/MRI in the differential diagnosis of dementia}},
journal = {Clinical nuclear medicine},
year = {2014},
doi = {10.1097/rlu.0b013e31829b9e5f},
pmid = {23856830},
url = {https://doi.org/10.1097/rlu.0b013e31829b9e5f}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The potential of brain imaging has grown rapidly with new modalities, hybrid combinations of existing modalities, and novel metabolic tracers.
- F-florbetapir is an amyloid plaque-binding molecule labeled to F that allows positron imaging of the amyloid deposition in the brain.
- This protein deposition is known to be one of the features in Alzheimer disease and therefore can be of interest in the differential diagnosis of dementia.
- We present 2 cases combining the new hybrid imaging modality PET/MRI, which offers molecular and morphological information, with F-florbetapir in the differential diagnosis of dementia.
Why it matters
This report describes two patients in whom PET/MRI combined with F-florbetapir was used to help tell different dementias apart. It is a small two-case report, so it does not show whether this imaging approach changes treatment, cure, or prevention of Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 34/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Clinical nuclear medicine) |
| Journal's citation record | 1 / 4 | Clinical Nuclear Medicine: journal h-index 90 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 17 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.2 citations a year over 14 year(s) since 2014 |
| Impact for its field and year | 2 / 6 | Cited 2.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author James K. O’Donnell: h-index 13 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Case Western Reserve University: institution h-index 1,159 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 23856830) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 34 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.